Dr. Schoenberg named chair at Albert Einstein
Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University, Bronx, NY, have named Mark Schoenberg, MD, professor and university chair of the department of urology. He will assume his new position in April 2014.
“I am pleased to welcome Dr. Schoenberg to Montefiore as chair of urology. He is a distinguished leader in the field with a passionate commitment to research and multidisciplinary patient care. Dr. Schoenberg will lead a team with a solid record of clinical, educational, and research excellence, and build upon this record to continue to advance the care of our patients,” said Steven M. Safyer, MD, president and CEO of Montefiore.
Dr. Schoenberg joins Montefiore from Johns Hopkins Medicine, Baltimore, where he currently serves as the Bernard L. Schwartz Distinguished Professor of Urology and director of urologic oncology.
During Dr. Schoenberg’s 20-year tenure at Johns Hopkins, his clinical practice has centered on the care of patients with all forms of bladder cancer. His research program focused on the translational validation of urinary markers for the early detection of cancer, the development of regenerative medicine solutions to challenges of lower urinary tract reconstruction after bladder removal surgery, and the development of minimally invasive therapies for urologic malignancies.
Dr. Schoenberg is the past chair of the medical advisory board of the Bladder Cancer Advocacy Network, the author of “The Guide to Living with Bladder Cancer,” co-editor of “The Textbook of Bladder Cancer,” a contributor to “Campbell’s Urology,” and a seminars editor of Urologic Oncology.
Dr. Schoenberg received his medical degree (Alpha Omega Alpha) in 1986 from the University of Texas Health Sciences Center, San Antonio, and completed his residency in general surgery and urology at the Hospital of the University of Pennsylvania, Philadelphia, in 1992. He served as chief resident and urology instructor there in 1992 before completing basic research and clinical urologic oncology fellowships at Johns Hopkins under the auspices of the American Cancer Society.